3644 results for «2777»
3644 results
Impact of imaging in treatment of bifurcation lesions - Part 1
22 May 2025 – From EuroPCR 2025
Investigate the critical role of intracoronary imaging in the management of bifurcation lesions. This session addresses challenges such as difficult side branch access and lesion complexity, highlighting the importance of strategy over chance. Learn from cases focusing on left main bifurcation, lesion de-calibration, and complex ostial...
Refine diagnosis to improve chronic heart failure care
22 May 2025 – From EuroPCR 2025
Refine diagnostic approaches to improve care in chronic heart failure patients. This session covers comparative pulmonary flow measurement techniques, prognostic significance of left atrial strain in mildly reduced ejection fraction, and serum interleukin-33 associations. Additionally, it reviews biopsy sheath contact confirmation during right ventricular biopsy and...
Navigating complexity: TAVI in challenging anatomies
22 May 2025 – From EuroPCR 2025
Navigate the complexities of TAVI in challenging anatomies. This session reviews anatomical variations such as horizontal aorta, iliofemoral tortuosity, low coronary ostia, bicuspid valves, and annular eccentricity, alongside preprocedural imaging and risk stratification. It further evaluates device selection and procedural adaptations essential for successful TAVI in...
Intracoronary image interpretation: from operator to artificial intelligence
22 May 2025 – From EuroPCR 2025
Explore the evolving landscape of intracoronary image interpretation from operator-dependent assessments to artificial intelligence (AI) assistance. This session features variability analysis between novices and experts in OCT interpretation, AI-driven plaque segmentation and quantification, comparisons of stent expansion assessments by core labs and AI software, and insights...
TAVI coronary access
22 May 2025 – From EuroPCR 2025
Gain expertise in managing coronary access challenges in TAVI patients. This session discusses when and how to treat coronary lesions in TAVI candidates, strategies to facilitate coronary approach post-TAVI, and long-term outcomes with practical tips through illustrative cases including primary PCI after CoreValve implantation and valve-in-valve...
Calcium and complications management in bifurcation
22 May 2025 – From EuroPCR 2025
Address calcium-related challenges and complication management in coronary bifurcation PCI. This session reviews the impact of intraprocedural complications during two-stent techniques, procedural success and one-year outcomes of intravascular lithotripsy in calcific bifurcations and unprotected left main PCI, and bench-test analyses of perforation management. Additionally, it compares...
Mitral TEER in challenging scenarios - Part 1
22 May 2025 – From EuroPCR 2025
Confront challenging clinical scenarios in mitral transcatheter edge-to-edge repair (TEER) with this session highlighting unique case experiences. Topics include innovative approaches to transcatheter mitral valve repair, urgent management of critical complications such as severe mitral regurgitation causing respiratory distress, and complex interventions in resource-limited settings such...
When angina cannot be cured with stents: what are the remaining options
22 May 2025 – From EuroPCR 2025
Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.
How to manage acute complications during bifurcation PCI
22 May 2025 – From EuroPCR 2025
Navigate acute complications during bifurcation PCI with expert case discussions demonstrating retrieval of fractured guide wires, managing procedural detours in DK crush stenting, distal wire perforations with fistula formation, and challenges such as stent displacement post-deployment. This session provides practical insights into complication management to optimize...
Beyond the intervention: outcomes of CTO PCI
22 May 2025 – From EuroPCR 2025
Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.
How to deal with left main culprit in NSTEMI
21 May 2025 – From EuroPCR 2025
This session offers a cross-geographic exchange on managing left main culprit lesions in NSTEMI patients. Learn different interventional approaches, risk evaluation for periprocedural complications, and diverse PCI management strategies tailored to this complex subgroup.
Main vessel stenting in DK-Crush: lessons from stepwise provisional strategy
- Optimisation of side branch stenting
- How to optimally deploy the second stent
Commented by Goran Stankovic and William Wijns
Part 3 of a 3-part series. Previous episode: How to correct incomplete crush and how to prevent lack of carina coverage
Design that delivers the future of TAVI
13 Feb 2026 – From PCR Tokyo Valves 2026
This session presents the future of TAVI valve design, emphasizing supra-annular valve benefits, strategies for managing concomitant coronary artery disease, and redo-TAVI approaches tailored for long-term patient management.
Learn from the experts: Evolut first implant technique and treatment strategies
15 Feb 2026 – From PCR Tokyo Valves 2026
This expert-led session offers an in-depth review of evolving clinical practices in aortic valve disease treatment, emphasizing the potential of the transcarotid approach as a primary alternative access route. It compares current strategies including TAVI, surgical aortic valve replacement (SAV), TAV-in-SAV, and TAVI explantation, while addressing...
Learn from the experts: lifetime management for Evolut first redo TAVI (TAV-in-TAV) and explant
14 Feb 2026 – From PCR Tokyo Valves 2026
This session offers an in-depth exploration of lifetime management strategies for patients undergoing Evolut first redo TAVI procedures, including TAV-in-TAV and explant techniques. It provides a comprehensive understanding of clinical decision-making algorithms, technical challenges, and key considerations for successful procedural planning and execution, supported by real-world...
Real world outcomes and strategies for optimal TEER across diverse DMR anatomies
14 Feb 2026 – From PCR Tokyo Valves 2026
This session develops a nuanced understanding of the complexity inherent in DMR cases, informed by the latest registry data. It highlights the capabilities of the PASCAL device in managing challenging anatomies and achieving predictable clinical results, alongside contemporary strategies for device selection and optimal placement to...
TAVI today and tomorrow: international trends and future direction
14 Feb 2026 – From PCR Tokyo Valves 2026
This session focuses on the evolving landscape of TAVI, emphasising lifetime management strategies with a focus on the first valve implanted. It provides a comprehensive discussion on representative patient profiles, current guidelines from various countries, and future outlooks, alongside recent long-term clinical results for the balloon-expandable...
Built to last: lifetime management for durability and beyond
14 Feb 2026 – From PCR Tokyo Valves 2026
This session addresses the principles of lifetime management aimed at durability and optimal long-term outcomes in complex valvular heart disease cases. Key topics include the critical importance of initial valve choice, practical tips for optimizing paravalvular leak (PVL) management, and advanced strategies for redo transcatheter aortic...
Protect the brain for TAVI - True potential of SENTINEL Cerebral Protection System
14 Feb 2026 – From PCR Tokyo Valves 2026
This session highlights the critical role of cerebral protection during TAVI procedures by focusing on the SENTINEL Cerebral Protection System. It reviews trends in the United States and Japan, presents clinical outcomes one year post-introduction in Japan, and examines key clinical trials through a meta-analysis comparing...
New horizons in structural heart disease therapy - Cutting-edge stroke prevention devices: WATCHMAN × SENTINEL
15 Feb 2026 – From PCR Tokyo Valves 2026
This session delves into the advances in stroke prevention for patients undergoing TAVI with atrial fibrillation, focusing on left atrial appendage closure (LAAC) and cerebral protection strategies. It highlights the evolving role of WATCHMAN devices and the SENTINEL Cerebral Protection System, emphasising perioperative stroke risk management...
